GT Biopharma, Inc. (GTBP)
0.71
-0.02
(-2.11%)
USD |
NASDAQ |
Jan 21, 16:00
0.6977
-0.01
(-1.73%)
Pre-Market: 09:22
GT Biopharma Free Cash Flow: -11.36M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| SELLAS Life Sciences Group, Inc. | -30.62M |
| Lyell Immunopharma, Inc. | -165.54M |
| Geron Corp. | -132.68M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Xencor, Inc. | -137.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.677M |
| Cash from Financing (Quarterly) | 0.977M |
| Free Cash Flow Per Share (Quarterly) | -0.9331 |
| Free Cash Flow to Equity (Quarterly) | -3.677M |
| Free Cash Flow to Firm (Quarterly) | -3.677M |
| Free Cash Flow Yield | -566.8% |